Equity · Healthcare
TEVA
NYSETeva Pharmaceutical (TEVA)
The line runs 36.13 USD on 10 August through 42.61 USD on 6 November, on a scale from 35.0 to 45.0. Days the market did not trade hold the previous close, flat.
- Market cap
- 49.7B USD
- P/E (TTM)
- 96.8
- Revenue, year to Dec 2025
- 17.3B USD
- EPS, diluted, year to Dec 2025
- 1.21 USD
- 52-week range
- 20.03 USD – 42.61 USD
- Avg volume
- 485.5K
- Mentions, 30 days
- 1
as of Nov 6, 2026
Have Teva Pharmaceutical (TEVA) insiders bought or sold shares recently?
In the 90 days to 9 Nov 2026, Teva Pharmaceutical insiders reported 7 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 20 Nov 2025, show no open-market purchase.
Form 4, 90 days to 9 Nov 2026, newest reported trade 5 Nov 2026
Buys 0Sells 7Net sold $18.72MOther filings 4
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 05 Nov 2026 | Sabag MarkSee "Remarks" | Sell | 46,000 | 1.9M USD |
| 04 Nov 2026 | Bergwerk DovInterim Cheif Legal Officer | Sell | 26,260 | 1.1M USD |
| 18 Sep 2026 | Savage BrianInterim Chief Legal Officer | Sell | 7,342 | 285K USD |
| 18 Sep 2026 | MIGNONE ROBERTODirector | Sell | 367,600 | 14.4M USD |
| 21 Aug 2026 | Weiss AmirChief Accounting Officer | Sell | 9,445 | 355K USD |
| 21 Aug 2026 | Satchi-Fainaro RonitDirector | Sell | 415 | 15K USD |
| 17 Aug 2026 | Lippman EvanEVP, Business Development | Sell | 18,600 | 680K USD |
| Sold | 7 open-market sales | 475,662 | $18.72M |
4 other filings in the window: grants, exercises, tax withholding and transfers, not trades
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 05 Nov 2026 | Sabag MarkSee "Remarks" | Option exercise | 46,000 | 1.6M USD |
| 04 Nov 2026 | Bergwerk DovInterim Cheif Legal Officer | Option exercise | 26,260 | 861K USD |
| 18 Sep 2026 | Savage BrianInterim Chief Legal Officer | Option exercise | 4,503 | 156K USD |
| 21 Aug 2026 | Weiss AmirChief Accounting Officer | Option exercise | 2,500 | 49K USD |
Which funds hold Teva Pharmaceutical (TEVA)?
13 of the 45 institutional funds we track reported a Teva Pharmaceutical position for the quarter ended 30 Jun 2026 — a combined 426.4M USD; the latest of those filings landed 02 Sep 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| Glenview Capital Management | Held (±25%) | 5,081,091 | 172.1M USD | −23.7% |
| Millennium Management | Added | 3,265,321 | 110.6M USD | +72.4% |
| Bridgewater Associates | Held (±25%) | 1,326,678 | 44.9M USD | +17.6% |
| Point72 Asset Management | Held (±25%) | 1,059,778 | 35.9M USD | −6.3% |
| Duquesne Family Office | Trimmed | 624,999 | 21.2M USD | −73.7% |
| Tudor Investment Corp | Held (±25%) | 490,000 | 16.6M USD | −10.0% |
| Two Sigma Investments | Trimmed | 231,287 | 7.8M USD | −36.9% |
| D. E. Shaw & Co. | Added | 180,647 | 6.1M USD | +29.0% |
| AQR Capital Management | Added | 107,729 | 3.6M USD | +43.2% |
| Citadel Advisors | New position | 73,304 | 2.5M USD |
Showing the 10 largest of 13 reported positions. The figures above count all of them.
Have members of Congress traded Teva Pharmaceutical (TEVA)?
The most recent congressional trade disclosed in Teva Pharmaceutical is a sale by Herbert C. Conaway, Jr. (house, NJ), dated 12 Sep 2016.
STOCK Act disclosures
| Traded | Member | Type | Amount | Filed after |
|---|---|---|---|---|
| 12 Sep 2016 | Herbert C. Conaway, Jr.house · Democrat–NJ | Sale | 1K USD–15K USD | 30 days |
| 11 May 2016 | Herbert C. Conaway, Jr.house · Democrat–NJ | Sale | 1K USD–15K USD | 23 days |
| 04 May 2016 | Herbert C. Conaway, Jr.house · Democrat–NJ | Sale | 1K USD–15K USD | 30 days |
| 12 Mar 2014 | Herbert C. Conaway, Jr.house · Democrat–NJ | Sale | 1K USD–15K USD | 159 days |
What has been filed or recorded for Teva Pharmaceutical (TEVA)?
The filings we hold for Teva Pharmaceutical, newest first: 8 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 13 Oct 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 13 Oct 2026 | Fails to deliver | Shares failed to deliver | 1,209 shares | 50K USD notional · <0.001% of shares out |
| 09 Oct 2026 | Fails to deliver | Shares failed to deliver | 6 shares | 236 USD notional · <0.001% of shares out |
| 06 Oct 2026 | Fails to deliver | Shares failed to deliver | 189 shares | 7K USD notional · <0.001% of shares out |
| 05 Oct 2026 | Fails to deliver | Shares failed to deliver | 50 shares | 2K USD notional · <0.001% of shares out |
| 02 Oct 2026 | Fails to deliver | Shares failed to deliver | 50 shares | 2K USD notional · <0.001% of shares out |
| 30 Sep 2026 | Fails to deliver | Shares failed to deliver | 50 shares | 2K USD notional · <0.001% of shares out |
| 30 Sep 2026 | Quarterly earnings | Q3 2026 reported | EPS 0.20 USD | |
| 30 Sep 2026 | Financials | Total assets | 40.0B USD | at period end |
| 30 Sep 2026 | Financials | Total equity | 8.0B USD | at period end |
| 25 Sep 2026 | Fails to deliver | Shares failed to deliver | 443,776 shares | 17.8M USD notional · 0.038% of shares out |
| 24 Sep 2026 | Fails to deliver | Shares failed to deliver | 45,509 shares | 1.8M USD notional · 0.004% of shares out |
| 30 Jun 2026 | Quarterly earnings | Q2 2026 reported | EPS −0.49 USD | |
| 31 Mar 2026 | Quarterly earnings | Q1 2026 reported | EPS 0.31 USD | |
| 31 Dec 2025 | Annual report | FY 2025 reported | EPS 1.21 USD | Revenue $1.50B |
| 31 Dec 2025 | Financials | Revenue | 17.3B USD | fiscal year |
| 31 Dec 2025 | Financials | Net income | 1.4B USD | fiscal year |
| 31 Dec 2025 | Financials | Diluted EPS | 1.21 USD | fiscal year |
| 30 Sep 2025 | Quarterly earnings | Q3 2025 reported | EPS 0.37 USD | |
| 30 Jun 2025 | Quarterly earnings | Q2 2025 reported | EPS 0.24 USD | |
| 31 Mar 2025 | Quarterly earnings | Q1 2025 reported | EPS 0.18 USD | |
| 31 Dec 2024 | Annual report | FY 2024 reported | EPS −1.45 USD |
What is Reddit saying about Teva Pharmaceutical (TEVA)?
Reddit mentioned TEVA 1 times in the 30 days to 8 November 2026, in 1 of the communities we track. All of them were scored for sentiment: 100% read bullish, 0% bearish and 0% neither. Reddit data updated 8 November 2026.
30-day window, Method
Mentions, 30 days 1Communities 1
How do Reddit mentions of Teva Pharmaceutical (TEVA) compare with its price?
Share ↗
Where Teva Pharmaceutical (TEVA) is discussed
30 days
| Community | Share | Mentions | Net sentiment |
|---|---|---|---|
| r/wallstreetbets | 100% | 1 | +0.11 |
Teva Pharmaceutical (TEVA): frequently asked questions
What did Teva Pharmaceutical shares close at?
Teva Pharmaceutical closed at 42.61 USD on 6 Nov 2026, up 2.01% on the close before. That is the end-of-day price from Finazon, not a live quote.
What is Teva Pharmaceutical’s market cap?
Teva Pharmaceutical is worth 49.7B USD by market value as of 6 Nov 2026, which is the share price times the shares on issue from its SEC filings.
What is Teva Pharmaceutical’s P/E ratio?
Teva Pharmaceutical has a price-to-earnings ratio of 96.8, as of 6 Nov 2026: the share price divided by what the company earned per share over the last four reported quarters. A higher number means the market pays more for each dollar of earnings.
What is Teva Pharmaceutical’s revenue?
Teva Pharmaceutical reported revenue of 17.3B USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings
Have Teva Pharmaceutical insiders bought or sold shares recently?
In the 90 days to 9 Nov 2026, Teva Pharmaceutical insiders reported 7 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 20 Nov 2025, show no open-market purchase. A further 4 filings were grants, awards, gifts or exercises rather than open-market trades. See Insiders
Which funds own Teva Pharmaceutical?
13 of the 45 funds we track reported a Teva Pharmaceutical position for the quarter ended 30 Jun 2026, per their SEC Form 13F filings. The largest reported positions were Glenview Capital Management, Millennium Management and Bridgewater Associates. See Funds
Have members of Congress traded Teva Pharmaceutical?
Yes. 4 trades in Teva Pharmaceutical appear in the congressional disclosures we hold; the latest is a sale by Herbert C. Conaway, Jr. (House, NJ) dated 12 Sep 2016, filed 12 Oct 2016. Amounts are disclosed as ranges, and a filing can follow the trade by up to 45 days. See Congress
When did Teva Pharmaceutical last report earnings?
Teva Pharmaceutical last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of 0.20 USD; no next date is announced in SEC filings yet. See Filings
What is Reddit saying about Teva Pharmaceutical?
Teva Pharmaceutical was mentioned 0 times in the last 7 days across the finance subreddits we track, and 1 times over the trailing 30 days. Of the 1 mentions scored for sentiment, 100% read bullish and 0% bearish. That is a social signal, not investment advice. See Reddit
Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
- TradingViewthe price chart widget, drawn by TradingView from their own data
- RedditReddit ingest across the tracked finance subreddits
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- House disclosuresU.S. House of Representatives financial disclosures
- SECSEC fails-to-deliver (CNS) data
- SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings